This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Sophora flavescens root
- DrugBank Accession Number
- DB14565
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Bitter root
- Dogol-evs root
- Ku shen
- Kushen
- Lightyellow sophora root
- Shargal lider root
- Shrubby sophora root
- Sle-tres root
- Sofora zheltovataya root
- Sophora angustifolia root
- Sophora root
- Sophorae flavescentis radix
- Sophorae radix
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Lacto Bella Y Sophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL) Gel Vaginal Bella Lab Co., Ltd. 2018-04-27 Not applicable US 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Lacto Bella Y Sophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL) Gel Vaginal Bella Lab Co., Ltd. 2018-04-27 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- IYR6K8KQ5K
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Recruiting Treatment Radiation Mucositis 1 4 Unknown Status Prevention Lung Cancer 1 2 Not Yet Recruiting Treatment Cervical Cancer 1 Not Available Completed Not Available Adverse Drug Reaction (ADR) / Safety Surveillance / Severe Adverse Events / Severe Adverse Reactions 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Vaginal - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 20, 2018 16:22 / Updated at June 12, 2020 16:53